Published by
@ShahidNShah
@ShahidNShah
June 13 to June 15, 2023
The Bostonian Boston, 26 North Street, Boston, Massachusetts, 02109, United States
Uniting biotech and pharma scientists to revolutionize ophthalmic drug development, the Retinal Imaging Biomarkers and Endpoints Summit encourages forward-thinking discussions to enhance the adoption of novel imaging-based approaches to determine retinal function and optimize development of regulatory accepted endpoints.
Join 60+ retinal imaging, innovation, R and D, preclinical and clinical experts from the likes of Genentech, AbbVie, Apellis, Janssen and Novartis to overcome the translational challenges of choosing and implementing novel ophthalmic imaging biomarkers and endpoints in your research, to accelerate earlier, non-invasive and personalised healthcare for ophthalmic and neurodegenerative patients.
Read on www.retinal-imaging-summit.com
Continue reading at retinal-imaging-summit.com
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 20, 2024 at 12:59pm